Biopharmaceutical manufacturing : progress, trends and challenges

Biopharmaceutical manufacturing : progress, trends and challenges / Ralf Pörtner, editor.

Tallennettuna:
Bibliografiset tiedot
Muut tekijät: Pörtner, Ralf
Aineistotyyppi: E-kirja
Kieli:English
Julkaistu: Cham : Springer, 2023.
Sarja:Cell engineering ; v. 11.
Aiheet:
Pharmaceutical biotechnology.
Drug factories.
Linkit:Click for online access
Sisällysluettelo:
  • Part I: Manufacturing of Recombinant Therapeutic Proteins
  • Chapter 1. Single-Use Systems in Biopharmaceutical Manufacture: State of the Art and Recent Trends (Jossen et al.)
  • Chapter 2. Recent Developments in Bioprocess Monitoring Systems (Rahmatnejad et al.)
  • Chapter 3. Advances in Characterization of Industrial Bioreactors for Cell Culture Process (Fitschen et al.)
  • Chapter 4. Continuous Bioprocessing for Upstream Process - Perfusion Process (Chotteau et al.)
  • Chapter 5. Continuous Bioprocessing for Downstream (Gerstweiler)
  • Chapter 6. Towards Digital Twin for Biopharmaceutical Processes: Concept and Progress (Ding et al.)
  • Chapter 7. Integrated Process and Supply Chain Design and Optimization (Triantafyllou et al.)
  • Chapter 8. Production of Complex Proteins in Plants From Farming to Manufacturing (Nausch et al.)
  • Chapter 9. Manufacturing of Recombinant Proteins Using Quality by Design (QbD) Methodology: Current Trend and Challenges (Shin and Landauer)
  • Chapter 10. Biopharma 4.0 for Biologics Manufacturing Under Pandemic Constraints (Schmidt et al.)
  • Chapter 11. Biopharma 4.0: Digital Technologies Driving Smart Manufacturing (Nargund et al.)
  • Part II: Manufacturing Aspects of Cell and Gene Therapy
  • Chapter 12. Essential Aspects of Mesenchymal Stem Cell Manufacturing (Fleischhammer et al.)
  • Chapter 13. Towards a Continuous Production of Human Mesenchymal Stromal Cells in a Chemically Defined Medium: Opportunities and Challenges for a Robust and Scalable Expansion Process (Tasto and Salzig)
  • Chapter 14. Biomanufacturing Aspects of Gene Therapy (Warnock)
  • Chapter 15. Manufacturing and Quality of Advanced Therapeutics: Cellular Therapies, CAR-T and Gene Therapies (van den Bos et al.).

Samankaltaisia teoksia